Usefulness of Immunosuppression for Giant Cell Myocarditis
Top Cited Papers
- 1 December 2008
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 102 (11), 1535-1539
- https://doi.org/10.1016/j.amjcard.2008.07.041
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosisEuropean Heart Journal, 2007
- Recovery from Giant Cell Myocarditis with ECMO Support and Utilisation of Polyclonal Antithymocyte Globulin: A Case ReportThe Thoracic and Cardiovascular Surgeon, 2006
- Cardiac Transplantation for Pediatric Giant Cell MyocarditisThe Journal of Heart and Lung Transplantation, 2006
- Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significanceEuropean Journal of Heart Failure, 2002
- Cytotoxic mAb from rheumatic carditis recognizes heart valves and lamininJCI Insight, 2000
- Idiopathic Giant-Cell Myocarditis — Natural History and TreatmentThe New England Journal of Medicine, 1997
- Giant cell myocarditis.1995
- In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis.Circulation, 1992
- A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fractionClinical Immunology and Immunopathology, 1990
- Giant cell myocarditis: dramatic haemodynamic and histologic improvement with immunoSuppressive therapyEuropean Heart Journal, 1987